Philidor Recent News
JPMorgan Isn't Concerned About Valeant's Ad Hoc Committee At All; Says Sum-Of-The-Parts Shows Upside
Valeant Shares Squeezed Higher As Ad Hoc Committee Closes Review, Finds No Added Issues
Former Valeant CFO: I Did Not Engage In Improper Conduct
Valeant Announces CEO Succession Plans And Financial Update; Bill Ackman Joins Board
Valeant Just Received 2 More Downgrades
Long-Time Valeant Bull Jefferies Cuts Price Target 40%
A Visual Look At Valeant's Dark Monday
Valeant Gets Closer To Left's $50 Target After New Accounting Fears
Valeant Pharma: The Empire Strikes Back
Piper Jaffray: Valeant's Business Could Be Broken Up In 2016
CIBC Analysts On Valeant: Questions Still Unanswered After Investor Day
Going From Philidor To Walgreens Gives Valeant Credibility, But There Are Still Questions
Does Valeant Have A Poland Problem?
Here's Why Valeant Is Worrying Deutsche Bank And Morgan Stanley
Valeant Investors: These 5 Companies Survived Major Accounting Scandals
EXCLUSIVE: Philidor Calls Short-Sellers 'Discredited' And 'Patently False'; Citron's Andrew Left Responds
Ackman To Investors: Hard Times Will Pay Off
Citron's Andrew Left Responds To Valeant's Declarations About His Report: 'I Put Out Information That Turned Out To Be True'
Citron Research Says It Will Not 'Dial Back Warnings' Regarding Valeant
Goldman Downgrades Valeant, Sees 'Long Road' For Controversial Stock
Valeant Ditches Philidor: Here's What It Really Means
Bank Of America Is Buying Valeant's Philidor Selloff
Depomed Validates Horizon Pharma Rejection Offer